Clinical Trial Update: Baricitinib in New-onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial of baricitinib in new-onset Type 1 Diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: St Vincent's Institute of Medical Research | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED